D. E. Shaw & Co., Inc.

Position in ESLA — Estrella Immunopharma, Inc.

CIK 1009207 New York, NY

Position in ESLA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

+$0 QoQ

Shares Held

87,500

0.0% QoQ

Ownership

0.203%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,328,350,520 across 188 Biotechnology names. ESLA ranks #175 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,625,825	$919,934,903
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,059,062	$350,411,843
3	BBIO	BridgeBio Pharma, Inc.	2,545,486	$189,027,789
4	PCVX	Vaxcyte, Inc.	2,865,318	$166,503,628
5	EXEL	Exelixis, Inc.	3,603,063	$154,535,371
6	HALO	Halozyme Therapeutics, Inc.	1,868,708	$120,774,597
7	PTCT	Ptc Therapeutics, Inc.	1,640,381	$111,759,157
8	VRTX	Vertex Pharmaceuticals Inc / Ma	248,960	$111,170,598

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31 ESLAW	—	87,500	0.0%	Shares	Defined	2026-05-15
2025-12-31 ESLAW	—	87,500	0.0%	Shares	Defined	2026-02-17
2025-09-30 ESLAW	—	87,500	0.0%	Shares	Defined	2025-11-14
2025-06-30 ESLAW	—	87,500	0.0%	Shares	Defined	2025-08-14
2025-03-31 ESLAW	—	87,500	0.0%	Shares	Defined	2025-05-15
2024-12-31 ESLAW	—	87,500	0.0%	Shares	Defined	2025-02-14
2024-09-30 ESLAW	—	87,500	0.0%	Shares	Defined	2024-11-14
2024-06-30 ESLAW	—	87,500	0.0%	Shares	Defined	2024-08-14
2024-03-31 ESLAW	—	87,500	0.0%	Shares	Defined	2024-05-15
2023-12-31 ESLAW	—	87,500	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.